In this case study, Advaxia Biologics overcame challenges it faced in its filling/capping suite using a Flexicon (part of Watson-Marlow Fluid Technology Solutions) FPC60 system with environmental barrier technology from Franz Ziel GmbH.
As CARBOGEN AMCIS opens its doors to a new sterile liquid drug product manufacturing facility in France, EPM caught up with Pascal Villemagne, CEO of CARBOGEN AMCIS, to discuss what this will mean for CARBOGEN's capabilities in freeze-dried products.
Jeong Jin-hyeok, associated director of Aseptic Filling, at Samsung Biologics, examines the lessons learned following the onset of COVID-19 and highlights how CDMO flexibility is helping to hail in an era of new therapeutic modalities.
Jon Sewell, special projects manager (Aseptic Filling Program Lead), Origin, looks at the rise of cleanrooms-on-demand in the pharma manufacturing sector, the challenges it helps to overcome and whether this could become the future blueprint.
Dr Heike Kofler - manager Technical Customer Support Europe at West Pharmaceutical Services explores the considerations for lyophilisation closure selection and processing to protect moisture-sensitive drug products.
Ben Wylie, senior product manager at ChargePoint Technology explains how single use technologies can help pharmaceutical manufacturers during bioprocessing.
Karen Bossert, vice president of operations at CDMO Particle Sciences, reviews the use of lyophilisation in pharma and the growing market need for this technology.
Tony Rhodes, sales manager at Telstar's Technology Centre for Barrier Isolation System discusses what operating pressure manufacturers should choose during the aseptic processing of potent materials in isolators.
